

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.84833130 |
| 2 | neutrophil activation involved in immune response (GO:0002283) | 5.49511130 |
| 3 | positive regulation of interferon-alpha production (GO:0032727) | 4.52065286 |
| 4 | regulation of interferon-alpha production (GO:0032647) | 4.22905269 |
| 5 | production of molecular mediator involved in inflammatory response (GO:0002532) | 4.07043110 |
| 6 | positive regulation by symbiont of host defense response (GO:0052509) | 4.02490567 |
| 7 | modulation by symbiont of host defense response (GO:0052031) | 4.02490567 |
| 8 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.02490567 |
| 9 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.02490567 |
| 10 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.02490567 |
| 11 | modulation by symbiont of host immune response (GO:0052553) | 4.02490567 |
| 12 | response to peptidoglycan (GO:0032494) | 3.90030516 |
| 13 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.89813775 |
| 14 | granulocyte activation (GO:0036230) | 3.87610775 |
| 15 | peptide catabolic process (GO:0043171) | 3.85832207 |
| 16 | immunoglobulin mediated immune response (GO:0016064) | 3.83774628 |
| 17 | intestinal absorption (GO:0050892) | 3.83070311 |
| 18 | neutrophil activation (GO:0042119) | 3.83064881 |
| 19 | negative regulation of complement activation (GO:0045916) | 3.82457045 |
| 20 | cellular glucuronidation (GO:0052695) | 3.79575556 |
| 21 | transepithelial transport (GO:0070633) | 3.75915238 |
| 22 | negative regulation of protein activation cascade (GO:2000258) | 3.75863459 |
| 23 | uronic acid metabolic process (GO:0006063) | 3.72420997 |
| 24 | glucuronate metabolic process (GO:0019585) | 3.72420997 |
| 25 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 3.71951942 |
| 26 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.64566347 |
| 27 | regulation of complement activation (GO:0030449) | 3.60959377 |
| 28 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.60335262 |
| 29 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 3.58562303 |
| 30 | regulation of protein activation cascade (GO:2000257) | 3.53721380 |
| 31 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.52339042 |
| 32 | L-phenylalanine metabolic process (GO:0006558) | 3.52339042 |
| 33 | type I interferon signaling pathway (GO:0060337) | 3.49522800 |
| 34 | cellular response to type I interferon (GO:0071357) | 3.49522800 |
| 35 | response to type I interferon (GO:0034340) | 3.49136250 |
| 36 | ethanol oxidation (GO:0006069) | 3.47891703 |
| 37 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.45175550 |
| 38 | primary alcohol catabolic process (GO:0034310) | 3.44607567 |
| 39 | polyketide metabolic process (GO:0030638) | 3.44157747 |
| 40 | doxorubicin metabolic process (GO:0044598) | 3.44157747 |
| 41 | daunorubicin metabolic process (GO:0044597) | 3.44157747 |
| 42 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.43401363 |
| 43 | epoxygenase P450 pathway (GO:0019373) | 3.41380105 |
| 44 | T-helper 1 type immune response (GO:0042088) | 3.39042300 |
| 45 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.36790231 |
| 46 | natural killer cell mediated immunity (GO:0002228) | 3.36790231 |
| 47 | reactive oxygen species biosynthetic process (GO:1903409) | 3.35798150 |
| 48 | respiratory burst (GO:0045730) | 3.35088922 |
| 49 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.34768073 |
| 50 | eosinophil chemotaxis (GO:0048245) | 3.33830228 |
| 51 | negative regulation of humoral immune response (GO:0002921) | 3.30920364 |
| 52 | positive regulation of interferon-beta production (GO:0032728) | 3.28312162 |
| 53 | regulation of metalloenzyme activity (GO:0048552) | 3.26784377 |
| 54 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.23703373 |
| 55 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.23703373 |
| 56 | macrophage activation involved in immune response (GO:0002281) | 3.21225597 |
| 57 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.18738558 |
| 58 | ethanol metabolic process (GO:0006067) | 3.18541490 |
| 59 | positive regulation of antigen processing and presentation (GO:0002579) | 3.17754599 |
| 60 | regulation of bile acid biosynthetic process (GO:0070857) | 3.17283203 |
| 61 | response to interferon-alpha (GO:0035455) | 3.16091497 |
| 62 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.15997169 |
| 63 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.14256968 |
| 64 | cellular response to interferon-alpha (GO:0035457) | 3.13441383 |
| 65 | complement activation, classical pathway (GO:0006958) | 3.12503469 |
| 66 | superoxide anion generation (GO:0042554) | 3.10515015 |
| 67 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.09596065 |
| 68 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.08481930 |
| 69 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.08380544 |
| 70 | flavonoid metabolic process (GO:0009812) | 3.08259144 |
| 71 | regulation of mononuclear cell migration (GO:0071675) | 3.08104506 |
| 72 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.06362550 |
| 73 | diterpenoid biosynthetic process (GO:0016102) | 3.04978974 |
| 74 | intestinal cholesterol absorption (GO:0030299) | 3.04779214 |
| 75 | positive regulation of interleukin-12 production (GO:0032735) | 3.03580202 |
| 76 | myeloid dendritic cell differentiation (GO:0043011) | 3.02516976 |
| 77 | L-phenylalanine catabolic process (GO:0006559) | 2.97850656 |
| 78 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.97850656 |
| 79 | negative regulation of viral genome replication (GO:0045071) | 2.97649632 |
| 80 | maintenance of gastrointestinal epithelium (GO:0030277) | 2.95444145 |
| 81 | regulation of activation of Janus kinase activity (GO:0010533) | 2.94838876 |
| 82 | eosinophil migration (GO:0072677) | 2.94778038 |
| 83 | xenobiotic catabolic process (GO:0042178) | 2.94607047 |
| 84 | desmosome organization (GO:0002934) | 2.93892454 |
| 85 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.93353232 |
| 86 | response to muramyl dipeptide (GO:0032495) | 2.92317466 |
| 87 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.90863693 |
| 88 | B cell mediated immunity (GO:0019724) | 2.90638955 |
| 89 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.89826196 |
| 90 | regulation of RIG-I signaling pathway (GO:0039535) | 2.89395505 |
| 91 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.88186919 |
| 92 | response to host immune response (GO:0052572) | 2.88186919 |
| 93 | acute-phase response (GO:0006953) | 2.88127260 |
| 94 | regulation of cholesterol homeostasis (GO:2000188) | 2.87857629 |
| 95 | transcytosis (GO:0045056) | 2.87411151 |
| 96 | response to interferon-beta (GO:0035456) | 2.87399568 |
| 97 | cellular response to interferon-beta (GO:0035458) | 2.87386491 |
| 98 | myeloid dendritic cell activation (GO:0001773) | 2.87328304 |
| 99 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.85312339 |
| 100 | drug catabolic process (GO:0042737) | 2.84425133 |
| 101 | cellular response to exogenous dsRNA (GO:0071360) | 2.84202300 |
| 102 | monocyte chemotaxis (GO:0002548) | 2.83583835 |
| 103 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.82221055 |
| 104 | positive regulation of type 2 immune response (GO:0002830) | 2.81128198 |
| 105 | primary alcohol metabolic process (GO:0034308) | 2.80450694 |
| 106 | bile acid metabolic process (GO:0008206) | 2.76987294 |
| 107 | detection of molecule of bacterial origin (GO:0032490) | 2.76472157 |
| 108 | cellular response to zinc ion (GO:0071294) | 2.75418391 |
| 109 | signal peptide processing (GO:0006465) | 2.74650930 |
| 110 | acute inflammatory response (GO:0002526) | 2.73877348 |
| 111 | regulation of cholesterol storage (GO:0010885) | 2.73330324 |
| 112 | myeloid cell activation involved in immune response (GO:0002275) | 2.72647299 |
| 113 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.72630422 |
| 114 | positive regulation of extracellular matrix organization (GO:1903055) | 2.72427703 |
| 115 | regulation of antigen processing and presentation (GO:0002577) | 2.72318954 |
| 116 | complement activation (GO:0006956) | 2.71143139 |
| 117 | retinal metabolic process (GO:0042574) | 2.69618651 |
| 118 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.69320459 |
| 119 | hepatocyte apoptotic process (GO:0097284) | 2.69054018 |
| 120 | angiotensin maturation (GO:0002003) | 2.68775172 |
| 121 | drug transmembrane transport (GO:0006855) | 2.67424833 |
| 122 | regulation of cholesterol esterification (GO:0010872) | 2.66985474 |
| 123 | complement activation, alternative pathway (GO:0006957) | 2.65837563 |
| 124 | regulation of chemokine biosynthetic process (GO:0045073) | 2.65632800 |
| 125 | regulation of vitamin metabolic process (GO:0030656) | 2.64660154 |
| 126 | positive regulation of heat generation (GO:0031652) | 2.64021047 |
| 127 | glycoside metabolic process (GO:0016137) | 2.63939851 |
| 128 | sequestering of metal ion (GO:0051238) | 2.63573769 |
| 129 | dendritic cell differentiation (GO:0097028) | 2.62651274 |
| 130 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.62647906 |
| 131 | drug metabolic process (GO:0017144) | 2.62211656 |
| 132 | positive regulation of T cell migration (GO:2000406) | 2.62010319 |
| 133 | negative regulation of lipid storage (GO:0010888) | 2.61857115 |
| 134 | wound healing, spreading of epidermal cells (GO:0035313) | 2.61026502 |
| 135 | leukocyte mediated cytotoxicity (GO:0001909) | 2.60804509 |
| 136 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.60387905 |
| 137 | defense response to protozoan (GO:0042832) | 2.59462993 |
| 138 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.58955835 |
| 139 | negative regulation of blood coagulation (GO:0030195) | 2.58712147 |
| 140 | negative regulation of hemostasis (GO:1900047) | 2.58712147 |
| 141 | COPI coating of Golgi vesicle (GO:0048205) | 2.56495895 |
| 142 | Golgi transport vesicle coating (GO:0048200) | 2.56495895 |
| 143 | negative regulation of interleukin-17 production (GO:0032700) | 2.56244555 |
| 144 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.55957501 |
| 145 | oligosaccharide catabolic process (GO:0009313) | 2.55512096 |
| 146 | positive regulation of lymphocyte migration (GO:2000403) | 2.55442939 |
| 147 | macrophage activation (GO:0042116) | 2.55311863 |
| 148 | positive regulation of interleukin-6 production (GO:0032755) | 2.54784968 |
| 149 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.54293245 |
| 150 | protein activation cascade (GO:0072376) | 2.53176540 |
| 151 | cytokine secretion (GO:0050663) | 2.52631622 |
| 152 | * negative regulation of coagulation (GO:0050819) | 2.52344643 |
| 153 | regulation of cellular extravasation (GO:0002691) | 2.51957335 |
| 154 | microglial cell activation (GO:0001774) | 2.51900402 |
| 155 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.51811239 |
| 156 | auditory receptor cell differentiation (GO:0042491) | 2.51563177 |
| 157 | dendritic cell chemotaxis (GO:0002407) | 2.51237160 |
| 158 | cellular response to virus (GO:0098586) | 2.51079652 |
| 159 | negative regulation of metanephros development (GO:0072217) | 2.50399647 |
| 160 | sterol transport (GO:0015918) | 2.50263642 |
| 161 | cholesterol transport (GO:0030301) | 2.50263642 |
| 162 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.50182540 |
| 163 | cobalamin metabolic process (GO:0009235) | 2.49946610 |
| 164 | drug transport (GO:0015893) | 2.49721328 |
| 165 | fibrinolysis (GO:0042730) | 2.49623144 |
| 166 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 2.49284297 |
| 167 | digestion (GO:0007586) | 2.47546157 |
| 168 | low-density lipoprotein particle remodeling (GO:0034374) | 2.47079127 |
| 169 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.46896301 |
| 170 | glycolipid catabolic process (GO:0019377) | 2.45628742 |
| 171 | negative regulation of wound healing (GO:0061045) | 2.45393508 |
| 172 | L-ascorbic acid metabolic process (GO:0019852) | 2.44600781 |
| 173 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.44380096 |
| 174 | lipoprotein metabolic process (GO:0042157) | 2.44315499 |
| 175 | glutathione biosynthetic process (GO:0006750) | 2.43371562 |
| 176 | sphingomyelin metabolic process (GO:0006684) | 2.41765014 |
| 177 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.41118521 |
| 178 | high-density lipoprotein particle remodeling (GO:0034375) | 2.40714811 |
| 179 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 2.39851414 |
| 180 | endocrine process (GO:0050886) | 2.39851414 |
| 181 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 2.39851414 |
| 182 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.39454643 |
| 183 | regulation of extracellular matrix disassembly (GO:0010715) | 2.39249045 |
| 184 | virion attachment to host cell (GO:0019062) | 2.38744748 |
| 185 | adhesion of symbiont to host cell (GO:0044650) | 2.38744748 |
| 186 | nonribosomal peptide biosynthetic process (GO:0019184) | 2.37645338 |
| 187 | positive regulation of glycoprotein metabolic process (GO:1903020) | 2.37170809 |
| 188 | bile acid and bile salt transport (GO:0015721) | 2.36612665 |
| 189 | plasma lipoprotein particle remodeling (GO:0034369) | 2.36049792 |
| 190 | protein-lipid complex remodeling (GO:0034368) | 2.36049792 |
| 191 | macromolecular complex remodeling (GO:0034367) | 2.36049792 |
| 192 | phenylpropanoid metabolic process (GO:0009698) | 2.33337624 |
| 193 | regulation of extracellular matrix organization (GO:1903053) | 2.32541942 |
| 194 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 2.31908912 |
| 195 | glutathione derivative biosynthetic process (GO:1901687) | 2.31243542 |
| 196 | glutathione derivative metabolic process (GO:1901685) | 2.31243542 |
| 197 | aromatic amino acid family catabolic process (GO:0009074) | 2.29460236 |
| 198 | glycosphingolipid catabolic process (GO:0046479) | 2.29070652 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.76288420 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.63714300 |
| 3 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.38845125 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.05870740 |
| 5 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.88039890 |
| 6 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.64089010 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.62127493 |
| 8 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.53682300 |
| 9 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.29485195 |
| 10 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.24439473 |
| 11 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.14891279 |
| 12 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.82864495 |
| 13 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.69274049 |
| 14 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.48789729 |
| 15 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.42404952 |
| 16 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.38917918 |
| 17 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.23659485 |
| 18 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.18787404 |
| 19 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.12548163 |
| 20 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.09701338 |
| 21 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.05118600 |
| 22 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.01333909 |
| 23 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.00965487 |
| 24 | GATA1_22025678_ChIP-Seq_K562_Human | 1.97455386 |
| 25 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.93876708 |
| 26 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.89563655 |
| 27 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.85043605 |
| 28 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.81037815 |
| 29 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.73067616 |
| 30 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.71379273 |
| 31 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.68419331 |
| 32 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.66790499 |
| 33 | * SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.66160151 |
| 34 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.64001938 |
| 35 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.63498283 |
| 36 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.59332190 |
| 37 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.57791336 |
| 38 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.53856661 |
| 39 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.53546996 |
| 40 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.52943415 |
| 41 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.50129397 |
| 42 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.48335659 |
| 43 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.45376404 |
| 44 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.44780618 |
| 45 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.43452279 |
| 46 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.43394499 |
| 47 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.43296639 |
| 48 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.43236123 |
| 49 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.42599642 |
| 50 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.41816043 |
| 51 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.38953119 |
| 52 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.38730440 |
| 53 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.38625809 |
| 54 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.38397342 |
| 55 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.38397342 |
| 56 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.37406396 |
| 57 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.36880762 |
| 58 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.36678471 |
| 59 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.35965378 |
| 60 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.35965378 |
| 61 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.35793189 |
| 62 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.34137166 |
| 63 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.32910907 |
| 64 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.28668827 |
| 65 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.27545727 |
| 66 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.26462347 |
| 67 | MYB_26560356_Chip-Seq_TH2_Human | 1.26427241 |
| 68 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.24151390 |
| 69 | CJUN_26792858_Chip-Seq_BT549_Human | 1.22968286 |
| 70 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.21939306 |
| 71 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.21867664 |
| 72 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.20489150 |
| 73 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.20440681 |
| 74 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.20384238 |
| 75 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.20064036 |
| 76 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.19249603 |
| 77 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.18854850 |
| 78 | TP53_16413492_ChIP-PET_HCT116_Human | 1.18654262 |
| 79 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.18446275 |
| 80 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.18045976 |
| 81 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.17351384 |
| 82 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.17196326 |
| 83 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.16701762 |
| 84 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.16436282 |
| 85 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.16433853 |
| 86 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.15565342 |
| 87 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.14443692 |
| 88 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.13751103 |
| 89 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 1.12816852 |
| 90 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.12622836 |
| 91 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12237648 |
| 92 | * TP63_23658742_ChIP-Seq_EP156T_Human | 1.11684512 |
| 93 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.11076837 |
| 94 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.09502210 |
| 95 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.08327975 |
| 96 | SPI1_23127762_ChIP-Seq_K562_Human | 1.07592242 |
| 97 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.07021664 |
| 98 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.04732190 |
| 99 | GATA3_26560356_Chip-Seq_TH2_Human | 1.03842004 |
| 100 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.02864111 |
| 101 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.02332699 |
| 102 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.01786040 |
| 103 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.01760465 |
| 104 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.00660723 |
| 105 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.99818032 |
| 106 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.99770067 |
| 107 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.98153867 |
| 108 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.98135228 |
| 109 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.97946874 |
| 110 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.97772511 |
| 111 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.97050191 |
| 112 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.96731115 |
| 113 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.95729820 |
| 114 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.94670591 |
| 115 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.93335019 |
| 116 | MYB_26560356_Chip-Seq_TH1_Human | 0.91877286 |
| 117 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.91492431 |
| 118 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91005102 |
| 119 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.90373879 |
| 120 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.90011239 |
| 121 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.89307994 |
| 122 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.89277343 |
| 123 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.87518679 |
| 124 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.86495996 |
| 125 | MAF_26560356_Chip-Seq_TH1_Human | 0.85611775 |
| 126 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.85060786 |
| 127 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.84930951 |
| 128 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.83507612 |
| 129 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.82315780 |
| 130 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.82195258 |
| 131 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.82094597 |
| 132 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.82026643 |
| 133 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.81928912 |
| 134 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.81317252 |
| 135 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.80836398 |
| 136 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.80552307 |
| 137 | * KLF5_25053715_ChIP-Seq_YYC3_Human | 0.80305653 |
| 138 | ATF3_27146783_Chip-Seq_COLON_Human | 0.79072213 |
| 139 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.76152538 |
| 140 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.76083405 |
| 141 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.74722521 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.01005683 |
| 2 | MP0005365_abnormal_bile_salt | 3.64886826 |
| 3 | MP0002148_abnormal_hypersensitivity_rea | 3.39223623 |
| 4 | MP0003436_decreased_susceptibility_to | 3.29549965 |
| 5 | MP0009785_altered_susceptibility_to | 3.27497166 |
| 6 | MP0005085_abnormal_gallbladder_physiolo | 3.04704657 |
| 7 | MP0006082_CNS_inflammation | 2.64189402 |
| 8 | MP0003724_increased_susceptibility_to | 2.53995208 |
| 9 | MP0005058_abnormal_lysosome_morphology | 2.51546709 |
| 10 | MP0002419_abnormal_innate_immunity | 2.51377782 |
| 11 | MP0005000_abnormal_immune_tolerance | 2.49498237 |
| 12 | MP0005025_abnormal_response_to | 2.45419697 |
| 13 | MP0002132_abnormal_respiratory_system | 2.42568618 |
| 14 | MP0000685_abnormal_immune_system | 2.34417586 |
| 15 | MP0001790_abnormal_immune_system | 2.23151505 |
| 16 | MP0005387_immune_system_phenotype | 2.23151505 |
| 17 | MP0008875_abnormal_xenobiotic_pharmacok | 2.14640102 |
| 18 | MP0002876_abnormal_thyroid_physiology | 2.12952122 |
| 19 | MP0004782_abnormal_surfactant_physiolog | 2.10584110 |
| 20 | MP0005671_abnormal_response_to | 2.03940488 |
| 21 | MP0002138_abnormal_hepatobiliary_system | 2.03414367 |
| 22 | MP0005310_abnormal_salivary_gland | 2.02867224 |
| 23 | MP0002452_abnormal_antigen_presenting | 1.98067729 |
| 24 | MP0003300_gastrointestinal_ulcer | 1.95536588 |
| 25 | MP0010155_abnormal_intestine_physiology | 1.93043974 |
| 26 | MP0002877_abnormal_melanocyte_morpholog | 1.87831860 |
| 27 | MP0001533_abnormal_skeleton_physiology | 1.87634326 |
| 28 | MP0004947_skin_inflammation | 1.85611928 |
| 29 | MP0002723_abnormal_immune_serum | 1.82846183 |
| 30 | MP0002006_tumorigenesis | 1.80492868 |
| 31 | MP0009764_decreased_sensitivity_to | 1.79015852 |
| 32 | MP0003303_peritoneal_inflammation | 1.75560222 |
| 33 | MP0001845_abnormal_inflammatory_respons | 1.72530125 |
| 34 | MP0004043_abnormal_pH_regulation | 1.72053552 |
| 35 | MP0003183_abnormal_peptide_metabolism | 1.69925777 |
| 36 | MP0001800_abnormal_humoral_immune | 1.63638968 |
| 37 | MP0003191_abnormal_cellular_cholesterol | 1.62354387 |
| 38 | MP0005464_abnormal_platelet_physiology | 1.61865296 |
| 39 | MP0005332_abnormal_amino_acid | 1.61179177 |
| 40 | MP0001819_abnormal_immune_cell | 1.61150838 |
| 41 | MP0010329_abnormal_lipoprotein_level | 1.57341391 |
| 42 | MP0002254_reproductive_system_inflammat | 1.56588600 |
| 43 | MP0002405_respiratory_system_inflammati | 1.56211392 |
| 44 | MP0002420_abnormal_adaptive_immunity | 1.55855728 |
| 45 | MP0008469_abnormal_protein_level | 1.54518749 |
| 46 | MP0002166_altered_tumor_susceptibility | 1.53543218 |
| 47 | MP0008004_abnormal_stomach_pH | 1.51805706 |
| 48 | MP0003448_altered_tumor_morphology | 1.48666952 |
| 49 | MP0001664_abnormal_digestion | 1.47373463 |
| 50 | MP0005220_abnormal_exocrine_pancreas | 1.47197881 |
| 51 | MP0003806_abnormal_nucleotide_metabolis | 1.45887426 |
| 52 | MP0009840_abnormal_foam_cell | 1.45143446 |
| 53 | MP0001853_heart_inflammation | 1.44921779 |
| 54 | MP0003195_calcinosis | 1.42837519 |
| 55 | MP0010234_abnormal_vibrissa_follicle | 1.40648176 |
| 56 | MP0003868_abnormal_feces_composition | 1.39564735 |
| 57 | MP0002998_abnormal_bone_remodeling | 1.38897060 |
| 58 | MP0003950_abnormal_plasma_membrane | 1.37868097 |
| 59 | MP0000858_altered_metastatic_potential | 1.37135327 |
| 60 | MP0004510_myositis | 1.36248858 |
| 61 | MP0003186_abnormal_redox_activity | 1.34035272 |
| 62 | MP0005257_abnormal_intraocular_pressure | 1.32988475 |
| 63 | MP0004272_abnormal_basement_membrane | 1.31805169 |
| 64 | MP0009780_abnormal_chondrocyte_physiolo | 1.30459431 |
| 65 | MP0010352_gastrointestinal_tract_polyps | 1.30296588 |
| 66 | MP0005023_abnormal_wound_healing | 1.30036174 |
| 67 | MP0005379_endocrine/exocrine_gland_phen | 1.26801419 |
| 68 | MP0000343_altered_response_to | 1.26074912 |
| 69 | MP0003172_abnormal_lysosome_physiology | 1.24549058 |
| 70 | MP0001666_abnormal_nutrient_absorption | 1.24182988 |
| 71 | MP0002277_abnormal_respiratory_mucosa | 1.23645566 |
| 72 | MP0001873_stomach_inflammation | 1.22869544 |
| 73 | MP0000462_abnormal_digestive_system | 1.21666724 |
| 74 | MP0005166_decreased_susceptibility_to | 1.20196649 |
| 75 | MP0004264_abnormal_extraembryonic_tissu | 1.19782229 |
| 76 | MP0006054_spinal_hemorrhage | 1.19203685 |
| 77 | MP0003075_altered_response_to | 1.18963399 |
| 78 | MP0010678_abnormal_skin_adnexa | 1.18336364 |
| 79 | MP0003566_abnormal_cell_adhesion | 1.18026581 |
| 80 | MP0003866_abnormal_defecation | 1.17472239 |
| 81 | MP0002693_abnormal_pancreas_physiology | 1.16056496 |
| 82 | MP0008438_abnormal_cutaneous_collagen | 1.15733910 |
| 83 | MP0002089_abnormal_postnatal_growth/wei | 1.14438677 |
| 84 | MP0002928_abnormal_bile_duct | 1.12506901 |
| 85 | MP0003453_abnormal_keratinocyte_physiol | 1.08112396 |
| 86 | MP0002118_abnormal_lipid_homeostasis | 1.07673922 |
| 87 | MP0003045_fibrosis | 1.06848693 |
| 88 | MP0009333_abnormal_splenocyte_physiolog | 1.06776092 |
| 89 | * MP0010386_abnormal_urinary_bladder | 1.06650239 |
| 90 | MP0002139_abnormal_hepatobiliary_system | 1.04727245 |
| 91 | MP0003252_abnormal_bile_duct | 1.04047220 |
| 92 | MP0000716_abnormal_immune_system | 1.02957214 |
| 93 | MP0009643_abnormal_urine_homeostasis | 1.00904712 |
| 94 | MP0000490_abnormal_crypts_of | 0.99115426 |
| 95 | MP0001765_abnormal_ion_homeostasis | 0.97661692 |
| 96 | MP0005390_skeleton_phenotype | 0.96913796 |
| 97 | MP0005165_increased_susceptibility_to | 0.95413508 |
| 98 | MP0008872_abnormal_physiological_respon | 0.94725941 |
| 99 | MP0005167_abnormal_blood-brain_barrier | 0.94141559 |
| 100 | MP0005319_abnormal_enzyme/_coenzyme | 0.93803685 |
| 101 | MP0002136_abnormal_kidney_physiology | 0.93507247 |
| 102 | MP0002168_other_aberrant_phenotype | 0.92861929 |
| 103 | MP0003705_abnormal_hypodermis_morpholog | 0.92850888 |
| 104 | MP0004883_abnormal_blood_vessel | 0.91718793 |
| 105 | MP0005164_abnormal_response_to | 0.91207557 |
| 106 | MP0005408_hypopigmentation | 0.90155110 |
| 107 | MP0005636_abnormal_mineral_homeostasis | 0.89357962 |
| 108 | MP0000609_abnormal_liver_physiology | 0.88860212 |
| 109 | MP0005360_urolithiasis | 0.88286996 |
| 110 | MP0000613_abnormal_salivary_gland | 0.87916139 |
| 111 | MP0010307_abnormal_tumor_latency | 0.87606833 |
| 112 | MP0005076_abnormal_cell_differentiation | 0.87070143 |
| 113 | MP0005397_hematopoietic_system_phenotyp | 0.86547216 |
| 114 | MP0001545_abnormal_hematopoietic_system | 0.86547216 |
| 115 | MP0005083_abnormal_biliary_tract | 0.86222615 |
| 116 | MP0009763_increased_sensitivity_to | 0.85853575 |
| 117 | MP0003795_abnormal_bone_structure | 0.85349369 |
| 118 | MP0002933_joint_inflammation | 0.85119683 |
| 119 | MP0002163_abnormal_gland_morphology | 0.83747180 |
| 120 | MP0003283_abnormal_digestive_organ | 0.81963337 |
| 121 | MP0001663_abnormal_digestive_system | 0.81841261 |
| 122 | MP0004019_abnormal_vitamin_homeostasis | 0.81271969 |
| 123 | MP0005084_abnormal_gallbladder_morpholo | 0.79412288 |
| 124 | MP0002429_abnormal_blood_cell | 0.78661274 |
| 125 | MP0005275_abnormal_skin_tensile | 0.78593147 |
| 126 | MP0002796_impaired_skin_barrier | 0.78035536 |
| 127 | MP0009278_abnormal_bone_marrow | 0.77682706 |
| 128 | MP0002398_abnormal_bone_marrow | 0.77524023 |
| 129 | MP0005381_digestive/alimentary_phenotyp | 0.75915390 |
| 130 | MP0000249_abnormal_blood_vessel | 0.75528672 |
| 131 | MP0000477_abnormal_intestine_morphology | 0.74873751 |
| 132 | MP0000604_amyloidosis | 0.74745280 |
| 133 | MP0001958_emphysema | 0.74568169 |
| 134 | MP0000371_diluted_coat_color | 0.73320149 |
| 135 | MP0001881_abnormal_mammary_gland | 0.73234271 |
| 136 | MP0001764_abnormal_homeostasis | 0.73198452 |
| 137 | MP0001346_abnormal_lacrimal_gland | 0.72454377 |
| 138 | MP0000569_abnormal_digit_pigmentation | 0.71922412 |
| 139 | MP0001756_abnormal_urination | 0.71826129 |
| 140 | MP0001270_distended_abdomen | 0.68810979 |
| 141 | MP0002896_abnormal_bone_mineralization | 0.66344948 |
| 142 | MP0005595_abnormal_vascular_smooth | 0.66094641 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 5.81978230 |
| 2 | Recurrent abscess formation (HP:0002722) | 5.59640724 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 5.18498699 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.07931939 |
| 5 | Vacuolated lymphocytes (HP:0001922) | 5.01697683 |
| 6 | Ileus (HP:0002595) | 4.54921993 |
| 7 | Abnormality of macrophages (HP:0004311) | 4.37662745 |
| 8 | Autoimmune thrombocytopenia (HP:0001973) | 4.27199429 |
| 9 | Interstitial pulmonary disease (HP:0006530) | 3.92044847 |
| 10 | Complement deficiency (HP:0004431) | 3.80796958 |
| 11 | Gingivitis (HP:0000230) | 3.75141569 |
| 12 | Fat malabsorption (HP:0002630) | 3.61852253 |
| 13 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.54248666 |
| 14 | Mediastinal lymphadenopathy (HP:0100721) | 3.50231572 |
| 15 | Vascular calcification (HP:0004934) | 3.49291454 |
| 16 | Malnutrition (HP:0004395) | 3.45335775 |
| 17 | Rectal prolapse (HP:0002035) | 3.43275130 |
| 18 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.38464434 |
| 19 | Increased cerebral lipofuscin (HP:0011813) | 3.32449506 |
| 20 | Abnormality of complement system (HP:0005339) | 3.31418342 |
| 21 | Steatorrhea (HP:0002570) | 3.26776717 |
| 22 | Cardiovascular calcification (HP:0011915) | 3.25774724 |
| 23 | Periodontitis (HP:0000704) | 3.19858512 |
| 24 | Systemic lupus erythematosus (HP:0002725) | 3.12453970 |
| 25 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.10301363 |
| 26 | Mitral stenosis (HP:0001718) | 3.09578076 |
| 27 | Recurrent skin infections (HP:0001581) | 3.07462989 |
| 28 | Orchitis (HP:0100796) | 3.06235735 |
| 29 | Myositis (HP:0100614) | 3.05947502 |
| 30 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.03749216 |
| 31 | Xanthomatosis (HP:0000991) | 3.01649698 |
| 32 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.00008587 |
| 33 | Mucopolysacchariduria (HP:0008155) | 3.00008587 |
| 34 | Dysostosis multiplex (HP:0000943) | 2.99879549 |
| 35 | Recurrent fungal infections (HP:0002841) | 2.96735176 |
| 36 | Male infertility (HP:0003251) | 2.94404288 |
| 37 | Pustule (HP:0200039) | 2.92169466 |
| 38 | Basal ganglia calcification (HP:0002135) | 2.83614275 |
| 39 | Increased IgM level (HP:0003496) | 2.80066045 |
| 40 | Axonal loss (HP:0003447) | 2.79226442 |
| 41 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.74196941 |
| 42 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.74196941 |
| 43 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.74196941 |
| 44 | Gout (HP:0001997) | 2.70907092 |
| 45 | Potter facies (HP:0002009) | 2.69156725 |
| 46 | Facial shape deformation (HP:0011334) | 2.69156725 |
| 47 | Conjugated hyperbilirubinemia (HP:0002908) | 2.67696975 |
| 48 | Azoospermia (HP:0000027) | 2.67514271 |
| 49 | Optic neuritis (HP:0100653) | 2.66689698 |
| 50 | Retrobulbar optic neuritis (HP:0100654) | 2.66689698 |
| 51 | Abnormality of glycolipid metabolism (HP:0010969) | 2.66297212 |
| 52 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.66297212 |
| 53 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.66297212 |
| 54 | Glucose intolerance (HP:0000833) | 2.63305383 |
| 55 | Tetraparesis (HP:0002273) | 2.63038909 |
| 56 | Vasculitis (HP:0002633) | 2.60365434 |
| 57 | Thick nail (HP:0001805) | 2.59574624 |
| 58 | Abnormal glucose tolerance (HP:0001952) | 2.58334131 |
| 59 | Abnormal pancreas size (HP:0012094) | 2.56197951 |
| 60 | Intrahepatic cholestasis (HP:0001406) | 2.53768137 |
| 61 | Prostate neoplasm (HP:0100787) | 2.51783698 |
| 62 | Esophageal varix (HP:0002040) | 2.51489673 |
| 63 | Deep venous thrombosis (HP:0002625) | 2.48709383 |
| 64 | Hyperactive renin-angiotensin system (HP:0000841) | 2.47995371 |
| 65 | Autoimmune hemolytic anemia (HP:0001890) | 2.46715857 |
| 66 | Premature loss of primary teeth (HP:0006323) | 2.44664135 |
| 67 | Hypobetalipoproteinemia (HP:0003563) | 2.44502825 |
| 68 | Focal segmental glomerulosclerosis (HP:0000097) | 2.44427761 |
| 69 | Myocardial infarction (HP:0001658) | 2.43145083 |
| 70 | Late onset (HP:0003584) | 2.42684857 |
| 71 | Hydroxyprolinuria (HP:0003080) | 2.42454131 |
| 72 | Abnormality of proline metabolism (HP:0010907) | 2.42454131 |
| 73 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.40613055 |
| 74 | Osteolytic defects of the hand bones (HP:0009699) | 2.40613055 |
| 75 | Micronodular cirrhosis (HP:0001413) | 2.37630562 |
| 76 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.31309324 |
| 77 | Glomerulonephritis (HP:0000099) | 2.30004125 |
| 78 | Glycosuria (HP:0003076) | 2.28932120 |
| 79 | Abnormality of urine glucose concentration (HP:0011016) | 2.28932120 |
| 80 | Recurrent viral infections (HP:0004429) | 2.28058963 |
| 81 | Chronic obstructive pulmonary disease (HP:0006510) | 2.27791670 |
| 82 | Obstructive lung disease (HP:0006536) | 2.27791670 |
| 83 | Glomerulosclerosis (HP:0000096) | 2.26280602 |
| 84 | Urticaria (HP:0001025) | 2.25808511 |
| 85 | Disinhibition (HP:0000734) | 2.23568650 |
| 86 | Renal tubular acidosis (HP:0001947) | 2.22077496 |
| 87 | Cheilitis (HP:0100825) | 2.21778736 |
| 88 | Hypergammaglobulinemia (HP:0010702) | 2.20768169 |
| 89 | Hemorrhage of the eye (HP:0011885) | 2.18793975 |
| 90 | Prolonged partial thromboplastin time (HP:0003645) | 2.17221072 |
| 91 | Recurrent pneumonia (HP:0006532) | 2.14109623 |
| 92 | Hematochezia (HP:0002573) | 2.13262051 |
| 93 | Osteomyelitis (HP:0002754) | 2.12398877 |
| 94 | Bone pain (HP:0002653) | 2.11798898 |
| 95 | Hypoplasia of the uterus (HP:0000013) | 2.11144835 |
| 96 | Pulmonary infiltrates (HP:0002113) | 2.10945669 |
| 97 | Flat acetabular roof (HP:0003180) | 2.09064867 |
| 98 | Vertebral compression fractures (HP:0002953) | 2.08483254 |
| 99 | Abnormality of vitamin metabolism (HP:0100508) | 2.07487803 |
| 100 | Increased CSF protein (HP:0002922) | 2.06504853 |
| 101 | Abnormality of the right ventricle (HP:0001707) | 2.05502787 |
| 102 | Chronic otitis media (HP:0000389) | 2.05252824 |
| 103 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.05029181 |
| 104 | Arterial thrombosis (HP:0004420) | 2.02170739 |
| 105 | Pathologic fracture (HP:0002756) | 2.01142902 |
| 106 | Recurrent cutaneous fungal infections (HP:0011370) | 2.00432878 |
| 107 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.00432878 |
| 108 | Nephritis (HP:0000123) | 2.00426999 |
| 109 | Gingival bleeding (HP:0000225) | 1.99385576 |
| 110 | Gastrointestinal infarctions (HP:0005244) | 1.99197674 |
| 111 | Tubulointerstitial fibrosis (HP:0005576) | 1.99036302 |
| 112 | Poor head control (HP:0002421) | 1.99026917 |
| 113 | Cellulitis (HP:0100658) | 1.98622099 |
| 114 | Amyloidosis (HP:0011034) | 1.98329713 |
| 115 | Abnormal biliary tract morphology (HP:0012440) | 1.98097287 |
| 116 | Abdominal distention (HP:0003270) | 1.96285959 |
| 117 | Right ventricular cardiomyopathy (HP:0011663) | 1.95961685 |
| 118 | Metabolic alkalosis (HP:0200114) | 1.95291780 |
| 119 | Petechiae (HP:0000967) | 1.94281890 |
| 120 | Stomatitis (HP:0010280) | 1.93106974 |
| 121 | Symptomatic seizures (HP:0011145) | 1.92777376 |
| 122 | Pigmentary retinal degeneration (HP:0001146) | 1.92750396 |
| 123 | Decreased circulating renin level (HP:0003351) | 1.90408318 |
| 124 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.90307476 |
| 125 | Dehydration (HP:0001944) | 1.90104704 |
| 126 | Abnormality of the common coagulation pathway (HP:0010990) | 1.88645637 |
| 127 | Beaking of vertebral bodies (HP:0004568) | 1.87103586 |
| 128 | Hypoglycemic coma (HP:0001325) | 1.87005517 |
| 129 | Chronic diarrhea (HP:0002028) | 1.86876551 |
| 130 | Arterial tortuosity (HP:0005116) | 1.86861697 |
| 131 | Progressive visual loss (HP:0000529) | 1.85844103 |
| 132 | Hyperuricemia (HP:0002149) | 1.85415475 |
| 133 | Increased purine levels (HP:0004368) | 1.85415475 |
| 134 | Hyperammonemia (HP:0001987) | 1.83922506 |
| 135 | Congenital sensorineural hearing impairment (HP:0008527) | 1.83667756 |
| 136 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.83327756 |
| 137 | Recurrent lower respiratory tract infections (HP:0002783) | 1.82005433 |
| 138 | Nausea (HP:0002018) | 1.81127130 |
| 139 | Joint hemorrhage (HP:0005261) | 1.80340507 |
| 140 | Loss of speech (HP:0002371) | 1.80083586 |
| 141 | Hypoglycemic seizures (HP:0002173) | 1.78249461 |
| 142 | Anorexia (HP:0002039) | 1.78093469 |
| 143 | Vascular tortuosity (HP:0004948) | 1.77903263 |
| 144 | Cervical subluxation (HP:0003308) | 1.77418754 |
| 145 | Abnormality of carpal bone ossification (HP:0006257) | 1.77114908 |
| 146 | Hemoptysis (HP:0002105) | 1.77011062 |
| 147 | Alkalosis (HP:0001948) | 1.76990789 |
| 148 | Alopecia of scalp (HP:0002293) | 1.76662114 |
| 149 | Hyperphosphatemia (HP:0002905) | 1.74343783 |
| 150 | Purpura (HP:0000979) | 1.74341360 |
| 151 | Hepatosplenomegaly (HP:0001433) | 1.74287776 |
| 152 | Abnormality of renin-angiotensin system (HP:0000847) | 1.73295900 |
| 153 | Exocrine pancreatic insufficiency (HP:0001738) | 1.72992582 |
| 154 | Abnormality of purine metabolism (HP:0004352) | 1.70049121 |
| 155 | Hypotension (HP:0002615) | 1.69947025 |
| 156 | Abnormality of the pericardium (HP:0001697) | 1.69768066 |
| 157 | Pancreatitis (HP:0001733) | 1.69273532 |
| 158 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.68842075 |
| 159 | Leukocytosis (HP:0001974) | 1.68137488 |
| 160 | Bronchiectasis (HP:0002110) | 1.67849993 |
| 161 | Hypophosphatemia (HP:0002148) | 1.67410156 |
| 162 | Thrombocytosis (HP:0001894) | 1.67089242 |
| 163 | Prolonged neonatal jaundice (HP:0006579) | 1.64952713 |
| 164 | Abnormality of vitamin B metabolism (HP:0004340) | 1.64836471 |
| 165 | Hypolipoproteinemia (HP:0010981) | 1.62343623 |
| 166 | Abnormality of chloride homeostasis (HP:0011422) | 1.62267683 |
| 167 | J-shaped sella turcica (HP:0002680) | 1.60748484 |
| 168 | Rickets (HP:0002748) | 1.60525696 |
| 169 | Proximal tubulopathy (HP:0000114) | 1.57798177 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 4.07689940 |
| 2 | PBK | 3.39884474 |
| 3 | RIPK4 | 3.21110186 |
| 4 | TBK1 | 3.17153070 |
| 5 | MST4 | 2.81832973 |
| 6 | BLK | 2.72721284 |
| 7 | FRK | 2.60748288 |
| 8 | IRAK3 | 2.52687246 |
| 9 | ERN1 | 2.52637217 |
| 10 | JAK3 | 2.38353028 |
| 11 | TYK2 | 2.36950752 |
| 12 | IRAK4 | 2.32027754 |
| 13 | MST1R | 2.26509705 |
| 14 | PIM2 | 2.08587478 |
| 15 | IKBKB | 2.07075964 |
| 16 | NEK9 | 2.06506528 |
| 17 | IKBKE | 2.02314166 |
| 18 | MAP3K12 | 1.98395462 |
| 19 | ACVR1B | 1.89028026 |
| 20 | MYLK | 1.78219698 |
| 21 | PIK3CA | 1.73851962 |
| 22 | JAK1 | 1.68097086 |
| 23 | NME2 | 1.66256834 |
| 24 | CHUK | 1.62018603 |
| 25 | STK39 | 1.61707168 |
| 26 | TAOK3 | 1.59070152 |
| 27 | EPHA2 | 1.56764761 |
| 28 | PIK3CG | 1.42813964 |
| 29 | ERBB3 | 1.40943562 |
| 30 | TRPM7 | 1.32435421 |
| 31 | KIT | 1.30869047 |
| 32 | MAP3K3 | 1.29442929 |
| 33 | MAPKAPK3 | 1.28278450 |
| 34 | PDK2 | 1.26507776 |
| 35 | RPS6KA4 | 1.22596617 |
| 36 | PTK6 | 1.19752590 |
| 37 | MAP3K2 | 1.17282704 |
| 38 | EPHA3 | 1.16190568 |
| 39 | INSRR | 1.14754712 |
| 40 | TESK1 | 1.14662649 |
| 41 | BMPR2 | 1.14511656 |
| 42 | MAP3K13 | 1.14178318 |
| 43 | EPHB1 | 1.09691647 |
| 44 | OXSR1 | 1.08457087 |
| 45 | ZAP70 | 1.05797047 |
| 46 | NUAK1 | 1.03953115 |
| 47 | PRKG2 | 0.99084128 |
| 48 | CSK | 0.98651720 |
| 49 | ABL2 | 0.95432661 |
| 50 | FGFR4 | 0.94412682 |
| 51 | MAP4K1 | 0.93263959 |
| 52 | JAK2 | 0.92983537 |
| 53 | RIPK1 | 0.92229496 |
| 54 | GRK1 | 0.91647545 |
| 55 | FLT3 | 0.91510012 |
| 56 | STK38L | 0.91294692 |
| 57 | BMX | 0.90700195 |
| 58 | MAP2K2 | 0.90603127 |
| 59 | SIK1 | 0.88938457 |
| 60 | MET | 0.87539096 |
| 61 | TGFBR2 | 0.87006570 |
| 62 | FGFR3 | 0.85830751 |
| 63 | SIK3 | 0.85455006 |
| 64 | BTK | 0.83293164 |
| 65 | PIM1 | 0.83239986 |
| 66 | AKT3 | 0.81235959 |
| 67 | BMPR1B | 0.79521800 |
| 68 | MAP2K6 | 0.78688873 |
| 69 | PDGFRA | 0.77689495 |
| 70 | TXK | 0.77667429 |
| 71 | TEC | 0.75357104 |
| 72 | LMTK2 | 0.74952351 |
| 73 | MATK | 0.73922088 |
| 74 | SYK | 0.73588183 |
| 75 | LRRK2 | 0.73066704 |
| 76 | EIF2AK2 | 0.71993925 |
| 77 | MAPK15 | 0.71556857 |
| 78 | STK10 | 0.70847020 |
| 79 | STK3 | 0.70052858 |
| 80 | CDC42BPA | 0.70043277 |
| 81 | CSF1R | 0.69578969 |
| 82 | MARK3 | 0.69393358 |
| 83 | MELK | 0.68814474 |
| 84 | LYN | 0.68243529 |
| 85 | MAPK11 | 0.66062965 |
| 86 | ADRBK2 | 0.65904480 |
| 87 | IRAK1 | 0.65898537 |
| 88 | ROCK1 | 0.63856573 |
| 89 | SCYL2 | 0.63711885 |
| 90 | PAK4 | 0.63157445 |
| 91 | PDPK1 | 0.63101582 |
| 92 | TRIB3 | 0.63076514 |
| 93 | PRKCD | 0.62530615 |
| 94 | YES1 | 0.60522093 |
| 95 | DYRK1B | 0.60370731 |
| 96 | STK4 | 0.57630413 |
| 97 | CDK8 | 0.56830232 |
| 98 | HCK | 0.56591529 |
| 99 | MAP3K1 | 0.56371886 |
| 100 | DAPK1 | 0.55887344 |
| 101 | PRKCE | 0.54739025 |
| 102 | PRKAA2 | 0.54239764 |
| 103 | TTN | 0.53944619 |
| 104 | NLK | 0.53610827 |
| 105 | ABL1 | 0.53424089 |
| 106 | LCK | 0.52270109 |
| 107 | ARAF | 0.51304817 |
| 108 | MAP3K5 | 0.48856640 |
| 109 | MAPKAPK2 | 0.48667773 |
| 110 | MAP2K3 | 0.48360228 |
| 111 | MAP3K11 | 0.45102934 |
| 112 | EPHB2 | 0.43903390 |
| 113 | FER | 0.43515298 |
| 114 | STK38 | 0.43330802 |
| 115 | EGFR | 0.43157122 |
| 116 | PTK2 | 0.42887113 |
| 117 | FGFR2 | 0.41097880 |
| 118 | PDK1 | 0.39952999 |
| 119 | HIPK2 | 0.39417770 |
| 120 | DAPK3 | 0.39170397 |
| 121 | GSK3A | 0.38719625 |
| 122 | BCR | 0.37437189 |
| 123 | ERBB4 | 0.37122828 |
| 124 | ERBB2 | 0.35604305 |
| 125 | LIMK1 | 0.35601573 |
| 126 | MAP2K1 | 0.34356416 |
| 127 | CDK6 | 0.34004770 |
| 128 | IGF1R | 0.33673086 |
| 129 | EIF2AK3 | 0.33624170 |
| 130 | PDGFRB | 0.32523108 |
| 131 | MAP3K7 | 0.32162215 |
| 132 | PRKACG | 0.32091706 |
| 133 | DDR2 | 0.32024052 |
| 134 | ILK | 0.30861532 |
| 135 | PRKCA | 0.29805641 |
| 136 | LATS1 | 0.29522345 |
| 137 | DAPK2 | 0.29378844 |
| 138 | PRKD2 | 0.29259041 |
| 139 | STK24 | 0.29121376 |
| 140 | SRC | 0.28765729 |
| 141 | ZAK | 0.28694634 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 2.85288378 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.67783687 |
| 3 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.54381702 |
| 4 | Legionellosis_Homo sapiens_hsa05134 | 2.53094079 |
| 5 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.50937938 |
| 6 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.37046688 |
| 7 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.35771593 |
| 8 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.34370461 |
| 9 | Allograft rejection_Homo sapiens_hsa05330 | 2.24102803 |
| 10 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.18151056 |
| 11 | Lysosome_Homo sapiens_hsa04142 | 2.14903158 |
| 12 | Pertussis_Homo sapiens_hsa05133 | 2.11680490 |
| 13 | Retinol metabolism_Homo sapiens_hsa00830 | 2.10274993 |
| 14 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.08467715 |
| 15 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.08341503 |
| 16 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.07948515 |
| 17 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.07607055 |
| 18 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.05487233 |
| 19 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.94157279 |
| 20 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.88738196 |
| 21 | Tuberculosis_Homo sapiens_hsa05152 | 1.87034395 |
| 22 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.86307484 |
| 23 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.84740619 |
| 24 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.77752110 |
| 25 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.77740008 |
| 26 | Malaria_Homo sapiens_hsa05144 | 1.77428416 |
| 27 | Other glycan degradation_Homo sapiens_hsa00511 | 1.77220599 |
| 28 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.75431058 |
| 29 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.74386252 |
| 30 | Influenza A_Homo sapiens_hsa05164 | 1.68955972 |
| 31 | Phagosome_Homo sapiens_hsa04145 | 1.68406813 |
| 32 | Measles_Homo sapiens_hsa05162 | 1.65534461 |
| 33 | Bile secretion_Homo sapiens_hsa04976 | 1.64169538 |
| 34 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.55922635 |
| 35 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.55797801 |
| 36 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.53271720 |
| 37 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.53113425 |
| 38 | Salmonella infection_Homo sapiens_hsa05132 | 1.51723821 |
| 39 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.49409577 |
| 40 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.44575443 |
| 41 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.43737605 |
| 42 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.38823454 |
| 43 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.38242336 |
| 44 | Apoptosis_Homo sapiens_hsa04210 | 1.35391878 |
| 45 | Asthma_Homo sapiens_hsa05310 | 1.35106662 |
| 46 | Mineral absorption_Homo sapiens_hsa04978 | 1.34231752 |
| 47 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.33158166 |
| 48 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.31500332 |
| 49 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.31149763 |
| 50 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.30082173 |
| 51 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.29792267 |
| 52 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.27754484 |
| 53 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.26624710 |
| 54 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.20258329 |
| 55 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.15837323 |
| 56 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.15283664 |
| 57 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.15186733 |
| 58 | Hepatitis C_Homo sapiens_hsa05160 | 1.11766264 |
| 59 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.11234407 |
| 60 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.11087229 |
| 61 | Protein export_Homo sapiens_hsa03060 | 1.10970629 |
| 62 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.10889371 |
| 63 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.09634399 |
| 64 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.09380709 |
| 65 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.09201960 |
| 66 | Shigellosis_Homo sapiens_hsa05131 | 1.08713825 |
| 67 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.08549528 |
| 68 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.04628650 |
| 69 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.04115484 |
| 70 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.00025383 |
| 71 | Amoebiasis_Homo sapiens_hsa05146 | 0.99167050 |
| 72 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.98339057 |
| 73 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.95694537 |
| 74 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.92004475 |
| 75 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.90916600 |
| 76 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.89315900 |
| 77 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.89121793 |
| 78 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.88936869 |
| 79 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.87120119 |
| 80 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.82265169 |
| 81 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.82182879 |
| 82 | Histidine metabolism_Homo sapiens_hsa00340 | 0.82100854 |
| 83 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.82048985 |
| 84 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.81893244 |
| 85 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.81081658 |
| 86 | Hepatitis B_Homo sapiens_hsa05161 | 0.78222343 |
| 87 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.78137813 |
| 88 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.77908705 |
| 89 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.77470218 |
| 90 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.76345941 |
| 91 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.75092236 |
| 92 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.75018592 |
| 93 | Galactose metabolism_Homo sapiens_hsa00052 | 0.73509679 |
| 94 | Viral myocarditis_Homo sapiens_hsa05416 | 0.73289176 |
| 95 | Peroxisome_Homo sapiens_hsa04146 | 0.73166271 |
| 96 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.72778604 |
| 97 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.71261922 |
| 98 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.71078532 |
| 99 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.69629997 |
| 100 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.67461216 |
| 101 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.65848556 |
| 102 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.65749111 |
| 103 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.63880515 |
| 104 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.61036557 |
| 105 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.56847501 |
| 106 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.54585669 |
| 107 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.52151747 |
| 108 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.51116153 |
| 109 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.50621067 |
| 110 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.49776370 |
| 111 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.48311235 |
| 112 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.47977713 |
| 113 | Adherens junction_Homo sapiens_hsa04520 | 0.47923933 |
| 114 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.47323042 |
| 115 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.47160199 |
| 116 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.45263950 |
| 117 | Prion diseases_Homo sapiens_hsa05020 | 0.44934580 |
| 118 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.43611373 |
| 119 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.43202641 |
| 120 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.42687602 |
| 121 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.41055468 |
| 122 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.40731320 |
| 123 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.39280390 |
| 124 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.38324046 |
| 125 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.37220024 |
| 126 | Insulin resistance_Homo sapiens_hsa04931 | 0.36781525 |
| 127 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.36032159 |
| 128 | Platelet activation_Homo sapiens_hsa04611 | 0.35365355 |
| 129 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.35356134 |
| 130 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.35353468 |
| 131 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.35113278 |
| 132 | ABC transporters_Homo sapiens_hsa02010 | 0.34716947 |
| 133 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.33654569 |
| 134 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.32904864 |
| 135 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.30949391 |
| 136 | Tight junction_Homo sapiens_hsa04530 | 0.30508779 |
| 137 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.29898727 |
| 138 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.29628699 |
| 139 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.28553471 |
| 140 | Metabolic pathways_Homo sapiens_hsa01100 | 0.27967995 |
| 141 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.27436486 |
| 142 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.26479521 |
| 143 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.24877228 |

